Delivery Order SPE2DB22D3009-SPE2DB24FBA12

Award Date 7/9/24
Potential Completion Date 7/30/24
Potential Value $38K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $23,425.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of VARIVAX Vaccine with Diluents, with a period of performance through July 29, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA) for a total ceiling value of $4,685.05. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division worth $5,622.06 to provide VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities...
This federal contract award, valued at $194,797.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VARIVAX vaccine with diluents, and has a completion date of March 17, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC...
This federal contract award, valued at $11,380.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the VARIVAX Vaccine with Diluents, with a completion date of July 1, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The contract, valued at $7,443.28, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. As the prime contractor, Amerisourcebergen leverages its expertise in...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of the VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The award is a delivery order with a firm fixed price of $9,559.70 and an ultimate completion date of May 28, 2024. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill government contracts, particularly for the Department of Defense (DoD) and Department of...
This federal contract award, valued at $2,811.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of VARIVAX vaccine with diluents, a critical medical product used by the Department of Defense (DoD) and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
This federal contract award, valued at $8,603.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VARIVAX vaccine with diluents. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award, valued at $7,371.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VARIVAX vaccine with diluents, and has a completion date of March 14, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB24FBA12
    Delivery Order

This federal contract award, valued at $38,417.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of VARIVAX vaccine with diluents, a critical pharmaceutical product used in healthcare programs.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

As a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government contracts, particularly for the Department of Defense and Veterans Affairs healthcare systems.

Generated 10/8/24, 9:09 AM